Best Healthcare Stocks for Benjamin Graham Investors
Top 25 healthcare stocks ranked by their Benjamin Graham fit score - every score computed from current financials against published criteria. Updated daily.
How We Rank These
Each stock is scored on a 0–100 scale across the Benjamin Graham criteria (moat, durability, valuation, financial health, capital allocation). The score is a deterministic function of the company's TTM financials - no opinion, no hand-tuning. Rows with insufficient data are excluded.
The Top 25
- #195/100KLACKLA CorporationA
Meets 3/7 Graham criteria - classic deep-value candidate.
Mkt cap
$236.01B
ROIC
37.17%
- #291/100EWEdwards Lifesciences CorporationA
Meets 4/7 Graham criteria - classic deep-value candidate.
Mkt cap
$48.58B
ROIC
12.06%
- #390/100HALOHalozyme Therapeutics, Inc.A
Meets 3/7 Graham criteria - classic deep-value candidate.
Mkt cap
$12.17B
ROIC
23.65%
- #490/100LLYEli Lilly and CompanyA
Meets 2/7 Graham criteria - classic deep-value candidate.
Mkt cap
$994.49B
ROIC
34.84%
- #589/100IRMDIRadimed CorporationA
Meets 4/7 Graham criteria - classic deep-value candidate.
Mkt cap
$1.05B
ROIC
21.38%
- #688/100WSTWest Pharmaceutical Services, Inc.A
Meets 4/7 Graham criteria - classic deep-value candidate.
Mkt cap
$24.37B
ROIC
15.24%
- #785/100LMATLeMaitre Vascular, Inc.A
Meets 4/7 Graham criteria - classic deep-value candidate.
Mkt cap
$1.84B
ROIC
9.43%
- #884/100AMGNAmgen Inc.A
Meets 2/7 Graham criteria - classic deep-value candidate.
Mkt cap
$204.01B
ROIC
15.02%
- #984/100CORTCorcept Therapeutics IncorporatedC
Meets 4/7 Graham criteria - classic deep-value candidate.
Mkt cap
$12.19B
ROIC
-1.23%
- #1082/100RPRXRoyalty Pharma plcA
Meets 3/7 Graham criteria - classic deep-value candidate.
Mkt cap
$33.87B
ROIC
8.43%
- #1181/100IDXXIDEXX Laboratories, Inc.A
Meets 3/7 Graham criteria - classic deep-value candidate.
Mkt cap
$39.81B
ROIC
40.66%
- #1281/100TECHBio-Techne CorporationA
Meets 4/7 Graham criteria - classic deep-value candidate.
Mkt cap
$11.31B
ROIC
4.75%
- #1381/100PODDInsulet CorporationA
Meets 4/7 Graham criteria - classic deep-value candidate.
Mkt cap
$9.15B
ROIC
16.39%
- #1480/100SHCSotera Health CompanyD
Meets 2/7 Graham criteria - classic deep-value candidate.
Mkt cap
$5.24B
ROIC
7.96%
- #1579/100XERSXeris Biopharma Holdings, Inc.D
Meets 2/7 Graham criteria - classic deep-value candidate.
Mkt cap
$1.36B
ROIC
12.84%
- #1679/100MSAMSA Safety IncorporatedB
Meets 4/7 Graham criteria - classic deep-value candidate.
Mkt cap
$7.03B
ROIC
14.03%
- #1778/100CDRECadre Holdings, Inc.B
Meets 3/7 Graham criteria - classic deep-value candidate.
Mkt cap
$1.22B
ROIC
7.38%
- #1877/100SYKStryker CorporationB
Meets 4/7 Graham criteria - classic deep-value candidate.
Mkt cap
$105.7B
ROIC
9.79%
- #1977/100HAEHaemonetics CorporationB
Meets 3/7 Graham criteria - classic deep-value candidate.
Mkt cap
$4.67B
ROIC
8.37%
- #2076/100PAHCPhibro Animal Health CorporationB
Meets 3/7 Graham criteria - classic deep-value candidate.
Mkt cap
$1.45B
ROIC
11.17%
- #2176/100PNTGThe Pennant Group, Inc.B
Meets 2/7 Graham criteria - classic deep-value candidate.
Mkt cap
$1.37B
ROIC
4.96%
- #2276/100UTHRUnited Therapeutics CorporationB
Meets 4/7 Graham criteria - classic deep-value candidate.
Mkt cap
$21.32B
ROIC
18.81%
- #2376/100ALNYAlnylam Pharmaceuticals, Inc.D
Meets 2/7 Graham criteria - classic deep-value candidate.
Mkt cap
$33.28B
ROIC
19.66%
- #2476/100NBIXNeurocrine Biosciences, Inc.B
Meets 4/7 Graham criteria - classic deep-value candidate.
Mkt cap
$15.88B
ROIC
13.68%
- #2576/100AAgilent Technologies, Inc.B
Meets 4/7 Graham criteria - classic deep-value candidate.
Mkt cap
$41.42B
ROIC
12.54%